How much funding has TRELLIS BIOSCIENCE, INC. raised?

TRELLIS BIOSCIENCE, INC. has raised $10.0M in total funding, most recently a Grant round.

Who are TRELLIS BIOSCIENCE, INC.'s investors?

TRELLIS BIOSCIENCE, INC.'s investors include CARB-X, National Institutes of Health, Unknown.

When was TRELLIS BIOSCIENCE, INC. founded?

TRELLIS BIOSCIENCE, INC. was founded in 2015.

Where is TRELLIS BIOSCIENCE, INC. headquartered?

TRELLIS BIOSCIENCE, INC. is headquartered in REDWOOD CITY, California, United States.

What industry is TRELLIS BIOSCIENCE, INC. in?

TRELLIS BIOSCIENCE, INC. operates in Biotech, Healthcare.

How many employees does TRELLIS BIOSCIENCE, INC. have?

TRELLIS BIOSCIENCE, INC. has 1-10 employees.

TRELLIS BIOSCIENCE, INC.

Harnessing the Human Immune System

REDWOOD CITY, United States · Founded 2015 · $10.0M raised

Biotech

Healthcare

Headquarters: REDWOOD CITY, California
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: trellisbio.com
Total Funding: $10.0M
Last Round: $10.0M GrantOct 2024
Rounds: 3

About

Trellis Bioscience is a clinical-stage biotechnology company that uses its proprietary CellSpot™ technology to discover rare, naturally optimized human monoclonal antibodies from healthy donor blood. The company targets infectious diseases and cancer with therapeutics that are safer and more effective due to their human origin. Trellis has derived five mAb therapeutic candidates with demonstrated superior binding affinity and broad-spectrum capabilities.

Summary

TRELLIS BIOSCIENCE, INC. is a Biotech company based in REDWOOD CITY, United States, founded in 2015. It has raised $10.0M in total across 3 rounds, most recently a $10.0M Grant round in Oct 2024. Investors include CARB-X, National Institutes of Health and Unknown.